Management of malignant teratoma: does referral to a specialist unit matter?
- 1 April 1993
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 341 (8851), 999-1002
- https://doi.org/10.1016/0140-6736(93)91082-w
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival.BMJ, 1991
- Medical audit, cancer registration, and survival in ovarian cancerThe Lancet, 1991
- Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland.BMJ, 1989
- Centralisation of treatment and survival rates for cancer.Archives of Disease in Childhood, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Changes in testicular cancer in ScotlandEuropean Journal of Cancer and Clinical Oncology, 1987
- Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other SitesBritish Journal of Urology, 1986
- Rare cancers and specialist centres.BMJ, 1986
- GEOGRAPHICAL VARIATION IN MORTALITY FROM CONDITIONS AMENABLE TO MEDICAL INTERVENTION IN ENGLAND AND WALESThe Lancet, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958